Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13174)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 18, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Adhoute X, Penaranda G, Raoul JL, Le Treut P, Bollon E, Hardwigsen J, Castellani P, Perrier H, Bourlière M. Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments. World J Hepatol 2016; 8(17): 703-715 [PMID: 27330679 DOI: 10.4254/wjh.v8.i17.703] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i17/703.htm |
| Number | Citing Articles |
| 1 |
Jessica Elderkin, Najeeb Al Hallak, Asfar S. Azmi, Hussein Aoun, Jeffrey Critchfield, Miguel Tobon, Eliza W. Beal. Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management. Cancers 2023; 15(21): 5118 doi: 10.3390/cancers15215118
|
| 2 |
Terrence CH Hui, Justin Kwan, Uei Pua. Advanced Techniques in the Percutaneous Ablation of Liver Tumours. Diagnostics 2021; 11(4): 585 doi: 10.3390/diagnostics11040585
|
| 3 |
Chaobin He, Yize Mao, Jun Wang, Yunda Song, Xin Huang, Xiaojun Lin, Shengping Li. The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. Journal of Gastrointestinal Surgery 2018; 22(7): 1239 doi: 10.1007/s11605-018-3756-3
|
| 4 |
Lior Charach, Lior Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis. EMJ Hepatology 2017; : 81 doi: 10.33590/emjhepatol/10311703
|
| 5 |
Berend R. Beumer, Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Robert A. de Man, Jan N.M. IJzermans, Bas Groot Koerkamp. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients. European Journal of Surgical Oncology 2022; 48(3): 492 doi: 10.1016/j.ejso.2021.09.012
|
| 6 |
Tung‐Hung Su, Sih‐Han Liao, Chun‐Ming Hong, Chun‐Jen Liu, Tai‐Chung Tseng, Chen‐Hua Liu, Hung‐Chih Yang, Pei‐Jer Chen, Ding‐Shinn Chen, Chi‐Ling Chen, Xavier Adhoute, Marc Bourlière, Jia‐Horng Kao. NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging. Journal of Gastroenterology and Hepatology 2019; 34(12): 2179 doi: 10.1111/jgh.14705
|
| 7 |
|
| 8 |
Neal M. Mineyev, Karla M. Chaffee, Joyce Wong. Clinical Algorithms in General Surgery. 2019; : 331 doi: 10.1007/978-3-319-98497-1_81
|
| 9 |
M Omar, K Farid, T Emran, F El-Taweel, A Tabll, M Omran. HCC-Mark: a simple non-invasive model based on routine parameters for predicting hepatitis C virus related hepatocellular carcinoma. British Journal of Biomedical Science 2021; 78(2): 72 doi: 10.1080/09674845.2020.1832371
|
| 10 |
Hossein Ghanaati, Mahyar Mohammadifard, Mahtab Mohammadifard. A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma. Journal of Family Medicine and Primary Care 2021; 10(10): 3553 doi: 10.4103/jfmpc.jfmpc_2347_20
|
| 11 |
Ragesh B. Thandassery, Charles A. Lavender, Abhilash Perisetti, Michael Beheshti. Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores. Abdominal Radiology 2023; 49(2): 631 doi: 10.1007/s00261-023-04111-9
|
| 12 |
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
|
| 13 |
Ece Meram, Colin Longhurst, Baran Umut Vardar, Kerim Karaoglu, Paul F. Laeseke, Orhan S. Ozkan. Evaluation of staging systems to predict prognosis in hepatocellular carcinoma patients treated with radioembolization. Heliyon 2022; 8(1): e08770 doi: 10.1016/j.heliyon.2022.e08770
|
| 14 |
Mark A. Healy, Michael A. Choti. Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies. Annals of Surgical Oncology 2022; 29(7): 4030 doi: 10.1245/s10434-022-11709-8
|
| 15 |
Marcus-Alexander Wörns, Peter Robert Galle. Patient prioritisation in HCC treatment: All (good) things come in threes. Journal of Hepatology 2018; 68(6): 1311 doi: 10.1016/j.jhep.2017.11.035
|
| 16 |
Tong Wu, Na Li, Fengyuan Luo, Zhihong Chen, Liyuan Ma, Tao Hu, Guini Hong, Hongdong Li. Screening prognostic markers for hepatocellular carcinoma based on pyroptosis-related lncRNA pairs. BMC Bioinformatics 2023; 24(1) doi: 10.1186/s12859-023-05299-9
|
| 17 |
Guoqing Zhang, Renfeng Li, Yilei Deng, Longshuan Zhao. Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry. Expert Review of Gastroenterology & Hepatology 2018; 12(5): 515 doi: 10.1080/17474124.2018.1453806
|
| 18 |
Lauren Tal Grinspan, Elizabeth C. Verna. Liver Anesthesiology and Critical Care Medicine. 2018; : 21 doi: 10.1007/978-3-319-64298-7_2
|
| 19 |
Chaobin He, Chongyu Zhao, Yu Zhang, Cheng Chen, Xiaojun Lin. An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection. Journal of Inflammation Research 2021; : 1859 doi: 10.2147/JIR.S311084
|
| 20 |
Hongyong Zhang, Yufeng Wang, Zhikui Liu, Bowen Yao, Changwei Dou, Meng Xu, Qing Li, Yuli Jia, Shengli Wu, Kangsheng Tu, Qingguang Liu. Retracted: Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation. FEBS Open Bio 2016; 6(12): 1227 doi: 10.1002/2211-5463.12139
|
| 21 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
|
| 22 |
Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang. Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection. Cancer Medicine 2023; 12(12): 13329 doi: 10.1002/cam4.6031
|
| 23 |
Pietro Gatti, Antonio Giorgio, Emanuela Ciracì, Italia Roberto, Alessandro Anglani, Spano Sergio, Fernando Rizzello, Valentina Giorgio, Stefano Semeraro. Hepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report. Journal of Ultrasound 2019; 22(3): 363 doi: 10.1007/s40477-019-00361-w
|